Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Surgical Treatment Pathways for Benign Prostatic Hyperplasia Based on Real-World Data

NCT07872085 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT07872085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07872085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Surgical Treatment Pathways for Benign Prostatic Hyperplasia Based on Real-World Data
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Not applicable
Overall status
Completed
Start date
March 10, 2026
Completion date
September 7, 2026
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, stress urinary incontinence (sui)